THE THINNING TALLY of coronavirus cases in India is diminishing the influence of Covid-19 on the domestic pharmaceutical industry’s sales and future plans. After having shown resilience in the toughest of times and after harnessing the immense opportunities that came with the pandemic, Indian pharma is now returning to business as usual, moving away from Covid-19-related products. Anand Rathi Equity Research’s research analyst Aarti Rao and research associate Maulik Varia say footfalls in dermatology (skin), stomatology (mouth), ophthalmology (eyes), neurology (nerve disorders) and gynaecology (pregnancy-related) have started to pick up. “We maintain our positive view on chronic focussed companies...,” the firm said in a recent report.
GROWTH DRIVERS
This story is from the October 30, 2022 edition of Business Today India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 30, 2022 edition of Business Today India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
REACHING FOR THE COUNTERS
DESPITE HEALTH CONCERNS, THE INCREASING POPULARITY OF OTC DRUGS HAS LED TO PHARMA MAJORS SEIZING THE CHANCE TO DIVERSIFY THEIR REVENUE STREAMS. THE RISING POPULARITY OF SKINCARE AND PERSONAL HEALTH HAS LED TO EASY ACCESS OF SEVERAL DERMATOLOGICAL PRODUCTS. FROM D2C BRANDS TO ESTABLISHED PLAYERS, PHARMA COMPANIES ARE LOOKING TO BITE INTO THE PIE
the art of time
THE SIXTH EDITION OF THE LVMH WATCH WEEK WAS HELD IN NEW YORK AND PARIS RECENTLY. WE LOOK AT SOME OF THE LATEST CREATIONS SHOWCASED
Celestial Disruption
ASTROLOGY, OR THE STUDY OF THE FUTURE FORETOLD BY CELESTIAL BODIES, IS EXPERIENCING A COSMIC TRANSFORMATION, FUELLED BY DIGITAL DISRUPTION, ARTIFICIAL INTELLIGENCE, AND A $7-BILLION FAITH MARKET
"MANUFACTURING HAS MOVED TO THE FOREFRONT"
Rahul Jain, BCG India Head, on the future of manufacturing, how India can capitalise on global trends and more
"Reignite the spirit of ownership"
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company
TRICITY TRIUMPHS
CHANDIGARH, MOHALI & PANCHKULA DELIVERED SOME OF THE LONGEST DRIVES THIS SEASON
"AIM TO TRIPLE PROFITS TO ₹2,500 CRORE BY FY28”
Anand Roy, MD and CEO of Star Health Insurance, on the future of the company, challenges in the health insurance sector, and more
WHITHER THE RUPEE?
THE RUPEE HAS DECLINED SHARPLY ALONG WITH OTHER CURRENCIES AS THE DOLLAR HAS STRENGTHENED AFTER DONALD TRUMP TOOK OFFICE AS THE PRESIDENT OF THE US. WILL THE RUPEE CONTINUE TO DEPRECIATE AND WHAT WILL THE IMPACT BE ON INDIA'S ECONOMY?
"Some of our states have to introspect and get their act together"
Finance Minister Nirmala Sitharaman on the measures announced in the recent Budget, India's growth prospects, global uncertainty and more
ZOMATO REBRANDED: More Than Just Delivery
With Blinkit growing rapidly, renaming Zomato to Eternal drives home the multifaceted nature of business
